Illumina, Inc.
Prices may be delayed up to 15 min. Not investment advice. News volume: articles in the 4Search index each day.
Key statistics
Against its peers
Compare in full ›| ILU.F | 300676.SZ | NTRA | QGEN | 4544.T | NEO | |
|---|---|---|---|---|---|---|
| Market cap | 30.24B | 16.52B | 56.36B | 10.50B | 217.00B | 2.22B |
| P/E (TTM) | 38.2 | — | — | 25.8 | 23.5 | — |
| Forward P/E | 39.9 | 246.9 | -2,198.8 | 19.5 | 39.3 | 54.5 |
| Price/book | 10.9 | 2.0 | 30.8 | 3.1 | 1.6 | 2.8 |
| Dividend yield | — | — | — | 0.69% | 3.22% | — |
| 1-year change | +95.30% | −21.90% | +94.39% | +14.37% | −0.56% | +61.36% |
| Today | −0.85% | +3.54% | +0.62% | +0.89% | +3.51% | +1.90% |
The closest companies by business and industry (Diagnostics & Research). Prices may be delayed up to 20 min.
Latest news
All ILU.F news ›Illumina partners with Singapore for whole genome sequencing research initiative
Vietnam Investment Review - VIR Illumina partners with Singapore for whole genome sequencing research initiative SINGAPORE â Media OutReach Newswire â 3 November 2026 â Illumina, Inc. (Nasdaq: ILMN) today announc
Icahn Settlement Ends Legal Saga of Illumina’s Failed Grail Deal
Bloomberg Law News Carl Icahn’s investment companies secured court approval for a settlement with Illumina Inc.‘s former corporate leaders, ending Delaware litigation over the DNA sequencing company’s failed $8 billion deal to acquire
Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal - Law360
Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal Law360 Try our Advanced Search for more refined results The Practice of Law Deep News & Analysis Chancery Ends Icahn Suit Over Illumina's $8B Grail Deal Law360 is on it, so you are,…
Illumina selected to help bring precision medicine into everyday healthcare in Singapore
Future-ready: Built to accelerate performance and value All Kits & Reagents Detect five DNA bases in a single assay while delivering concurrent genetic and epigenetic insights All Selection & Planning Tools Take the guesswork out of your…
Illumina Inc Selected To Provide Whole-Genome Sequencing Services For SG-INSIGHT Study In Singapore
marketscreener.com had been selected to provide whole-genome sequencing services for the SG-INSIGHT study, a cohort under Phase III of Singapore's National Precision Medicine programme The study is e
Illumina, Ultima Selected for Singapore's SG-INSIGHT Program
Illumina, Ultima Selected for WGS in Next Phase of Singapore’s Precision Medicine Program GenomeWeb Illumina, Ultima Selected for WGS in Next Phase of Singaporeâs Precision Medicine Program
Illumina, Inc. (ILMN) Selected for Singapore Study of Around 450,000 People
TradingView Illumina, Inc. (ILMN) Selected for Singapore Study of Around 450,000 People Illumina was selected to provide whole-genome sequencing services for Singapore's SG-INSIGHT study, expected to include approximately 4
Illumina, Inc. (NASDAQ:ILMN) Edges Up 0.60% to USD 271.04
Price Action and Trading Activity Key Risks and Uncertainties Q: What are the ticker and exchange for Illumina, Inc.? A: Illumina, Inc. trades under the ticker ILMN on the Nasdaq, written as NASDAQ:ILMN. Q: How did Illumina, Inc.…
What Sent Illumina Stock Lower?
Illumina (ILMN) stock fell 18.6% on Friday, October 30, 2026, while the S&P 500 lost 1.8%. The drop came the day after Illumina reported its third-quarter results on October 29 and raised its outlook for the full year. So what was in that…
Illumina (NASDAQ:ILMN) reports sales below analyst estimates in Q3 2026 earnings, stock drops 16%
Genomics company Illumina (NASDAQ:ILMN) missed Wall Street’s revenue expectations in Q3 2026 as revenue rose 4.2% year on year to $1.13 billion. On the other hand, the company’s full-year revenue guidance of $4.65 billion at the midpoint…
From the 4Search news index, newest first.
In the news
Mentioned with
People in the coverage
Themes
Most coverage from
- marketscreener.com22
- tradingview.com9
- seekingalpha.com6
- stocktitan.net5
- theglobeandmail.com5
Finance and business coverage in the 4SEARCH.business news index: articles that name it in the headline, or in the text beside its ticker. Sentiment is the index's own reading of the latest 94 articles, not a forecast.